How To Assess The Bacterial Burden Of DFUs

Guy Pupp, DPM, FACFAS, and Robert Koivunen, DPM

1. Lee KH. Tissue-engineered human living skin substitutes: development and clinical application. Yonsei Med J. Dec 2000;41(6):774-779.
2. Available at . Published 2007. Accessed May 31, 2012.
3. Lazarus GS, Cooper DM, Knighton DR, Percoraro RE, Rodeheaver G, Robson MC. Definitions and guidelines for assessment of wounds and evaluation of healing. Wound Repair Regen. 1994;2(3):165-170.
4. Veves A, Falanga V, Armstrong DG, Sabolinski ML. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Apligraf Diabetic Foot Ulcer Study. Diabetes Care. 2001; 24(2):290-295.
5. Harrington C, Zagari MJ, Corea J, Klitenic J. A cost analysis of diabetic lower-extremity ulcers. Diabetes Care. 2000;23(9):1333-1338.
6. Paquette D, Falanga V. Leg ulcers. Clin Geriatr Med. 2002; 18(1):77-88, vi.
7. Steed DL. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group. J Vasc Surg. 1995;21(1):71-78.
8. Veves A, Sheehan P, Pham HT. A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers. Arch Surg. 2002; 137(7):822-827.
9. Gentzkow GD, Iwasaki SD, Hershon KS. Use of Dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care. 1996; 19(4):350-354.
10. Cavanagh PR, Lipsky BA, Bradbury AW, Botek G. Treatment for diabetic foot ulcers. Lancet. 2005; 366(9498):1725-1735.
11. Armstrong DG, Boulton AJ. Pressure offloading and “advanced” wound healing: isn’t it finally time for an arranged marriage? Int J Low Extrem Wounds. Dec 2004;3(4):184-187.
12. Edwards R, Harding KG. Bacteria and wound healing. Curr Opin Infect Dis. 2004; 17(2):91-96.
13. Davis SC, Martinez L, Kirsner R. The diabetic foot: the importance of biofilms and wound bed preparation. Curr Diab Rep. 2006;6(6):439-445.
14. Harrison-Balestra C, Cazzaniga AL, Davis SC, Mertz PM. A wound-isolated Pseudomonas aeruginosa grows a biofilm in vitro within 10 hours and is visualized by light microscopy. Dermatol Surg. 2003; 29(6):631-635.
15. Schierle CF, De la Garza M, Mustoe TA, Galiano RD. Staphylococcal biofilms impair wound healing by delaying reepithelialization in a murine cutaneous wound model. Wound Repair Regen. 2009; 17(3):354-359.
16. Percival SL, Cutting KF. Biofilms: possible strategies for suppression in chronic wounds. Nursing Standard 2009; 23(32):64-72.
17. Brady RA, Leid JG, Calhoun JH, Costerton W, Shirtliff ME. Osteomyelitis and the role of biofilms in chronic infection. FEMS Immunol Med Microbiol. 2008 Jan; 52(1):13-22.
18. Marston WA, Davies, SW, Armstrong B, et al. natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization. J Vasc Surg 2006; 44(1):108-114.
19. Apelqvist J, Larsson J, Agardh CD. Long-term prognosis for diabetic patients with foot ulcers. J Intern Med 1993; 233(6):485-491.
20. Pohjolainen T, Alaranta H. Ten-year survival of Finnish lower limb amputees. Prosthet Orthot Int 1998; 22(1):10-16.
21. Hill KE, Malic S, McKee R, et al. An in vitro model of chronic wound biofilms to test wound dressings and assess antimicrobial susceptibilities. J Antimicrobial Chemotherapy. 2010; 65(6):1195–1206.
22. Dowd SE, Sun Y, Secor PR, et al. Survey of bacterial diversity in chronic wounds using pyrosequencing DDGE and full ribosome shotgun sequencing. BMC Microbiology. 2008; 43(3):1471–2180.
23. Hurlow J, Bowler P. Clinical experience with wound biofilm and management: a case series. Ostomy Wound Management. 2009; 55(4):38–49.
24. Data on file, PathoGenius Laboratories, Lubbock, Texas.
25. Hoiby N, Ciofu O, Johansen HK, et al. The clinical impact of bacterial biofilms. Int J Oral Sci. 2011; 3(2):55-65.

Add new comment